Parker Institute for Cancer Immunotherapy shared a post on LinkedIn:
‘Patients shouldn’t have to wait 10-15 years for life-saving innovations to reach them’
Said PICI CEO Karen Knudsen in a recent piece from Ron Leuty in San Francisco Business Times.
That vision is at the heart of the work underway at PICI, where the organization is helping transform how breakthrough cancer therapies move from discovery to patients.
From advancing personalized cancer vaccines to building new models that accelerate commercialization, PICI is bringing together researchers, clinicians, investors, and advocates to accelerate the future of cancer treatment.
Thank you to Ron Leuty and the San Francisco Business Times for capturing the urgency, optimism, and momentum driving this next era of cancer immunotherapy.”
Other articles about Parker Institute for Cancer Immunotherapy and Karen Knudsen on OncoDaily.